Rosalind Advisors, Inc.

CIK

1622627

Location

TORONTO, A6

Portfolio Value

Small $266,977,310

Diversification

Diversified

Filing Date

Global Rank

#5,442 / 8,807 ▼ 454

Top Industry

Biotechnology 64.8%

Period ended 4 months ago

Filed Aug 14, 2026 · 2mo

11 quarters · since Dec 2023

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Unknown

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Concentrated

The top 10 positions are 74.7% of the book (60%+)

Turnover

Medium turnover

64.3% over the last four quarters (30% to under 100%)

Horizon

Medium horizon

Value-weighted holding period 7.0 quarters (4 to under 12)

Closest benchmark: the Russell 2000 as of 2026-06-30, active share 99.3%; sector active share 90.6% against the combined 13F book's sector weights.

Over time 11 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

29 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

15.6%

+3.0 pts

Top 5

50.1%

+8.5 pts

Top 10

74.7%

+7.5 pts

HHI

743

Diversified+166

Portfolio Trend

11 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$266,977,310	29

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

7 positions

Ticker	Company	Δ Shares	Shares	Value
VSTM	Verastem, Inc.	+1,848,034	3,986,509	$15,228,464
TLPH	Talphera, Inc.	+1,815,585	5,169,501	$5,324,586
RGNT	Regentis Biomaterials Ltd.	+450,175	701,685	$2,476,948
HELP	Helus Pharma Inc.	+425,000	1,956,814	$12,934,540
FENC	Fennec Pharmaceuticals Inc.	+279,800	3,188,001	$34,271,010
NRXS	Neuraxis, INC	+221,917	508,055	$3,713,882
BFRI	Biofrontera Inc.	+111,647	1,275,609	$1,206,726
No positions match the current search.

Trimmed

Positions the filer reduced

11 positions

Ticker	Company	Δ Shares	Shares	Value
XERS	Xeris Biopharma Holdings, Inc.	−322,719	2,908,981	$23,039,129
OKUR	OnKure Therapeutics, Inc.	−293,763	150,000	$684,000
MYO	Myomo, Inc.	−209,386	3,637,886	$3,783,401
PYPD	PolyPid Ltd.	−208,471	389,455	$1,978,431
BCRX	Biocryst Pharmaceuticals Inc	−201,553	721,504	$7,215,040
CLDX	Celldex Therapeutics, Inc.	−130,000	200,000	$7,442,000
AVIR	Atea Pharmaceuticals, Inc.	−101,305	1,070,550	$4,978,057
PCVX	Vaxcyte, Inc.	−90,000	200,000	$11,626,000
VOR	Vor Biopharma Inc.	−51,400	648,600	$11,940,726
EYPT	EyePoint, Inc.	−48,507	988,230	$14,131,689
SVRA	Savara Inc	−25,600	3,178,121	$19,577,225
No positions match the current search.

New Positions

Positions the filer opened this quarter

3 positions

Ticker	Company	Shares	Value
ABVX	Abivax S.A.	20,869	$2,781,002
SPRB	Spruce Biosciences, Inc.	20,000	$1,080,000
PEPG	PepGen Inc.	350,000	$630,000
No positions match the current search.

Sold Out

Positions the filer fully exited

6 positions

Ticker	Company	Shares	Value
CGON	CG Oncology, Inc.	100,000	$6,768,000
VRDN	Viridian Therapeutics, Inc.\DE	250,401	$4,897,843
DFTX	Definium Therapeutics, Inc.	125,000	$2,362,500
LPCN	Lipocine Inc.	221,616	$1,770,711
AVTX	Avalo Therapeutics, Inc.	75,000	$1,119,750
ANNX	Annexon, Inc.	200,000	$1,108,000
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

29 tracked positions · $266,977,310 total · filing declares 35 positions · $269,201,776 · as of Jun 30, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
DCTH	Delcath Systems, Inc. Healthcare	Held	3,300,389	0	$41,551,897	+35.7%	11	before history	15.56%
FENC	Fennec Pharmaceuticals Inc. Healthcare	Added	3,188,001	+279,800	$34,271,010	+91.6%	7	$6.54	12.84%
XERS	Xeris Biopharma Holdings, Inc. Healthcare	Reduced	2,908,981	-322,719	$23,039,129	+22.9%	11	before history	8.63%
SVRA	Savara Inc Healthcare	Reduced	3,178,121	-25,600	$19,577,225	+11.9%	7	$3.31	7.33%
VSTM	Verastem, Inc. Healthcare	Added	3,986,509	+1,848,034	$15,228,464	+34.4%	7	$5.19	5.70%
XFOR	X4 Pharmaceuticals, Inc Healthcare	Held	3,214,766	0	$15,012,957	+13.1%	4	$3.15	5.62%
EYPT	EyePoint, Inc. Healthcare	Reduced	988,230	-48,507	$14,131,689	+5.7%	4	$12.77	5.29%
HELP	Helus Pharma Inc. Healthcare	Added	1,956,814	+425,000	$12,934,540	+75.9%	7	$7.76	4.84%
VOR	Vor Biopharma Inc. Healthcare	Reduced	648,600	-51,400	$11,940,726	−4.4%	2	$14.10	4.47%
PCVX	Vaxcyte, Inc. Healthcare	Reduced	200,000	-90,000	$11,626,000	−31.0%	2	$54.29	4.35%
MDWD	MediWound Ltd. Healthcare	Held	749,054	0	$11,011,093	−8.8%	11	before history	4.12%
CLDX	Celldex Therapeutics, Inc. Healthcare	Reduced	200,000	-130,000	$7,442,000	−28.9%	2	$27.26	2.79%
BCRX	Biocryst Pharmaceuticals Inc Healthcare	Reduced	721,504	-201,553	$7,215,040	−17.9%	2	$7.77	2.70%
PROF	Profound Medical Corp. Healthcare	Held	828,118	0	$5,506,984	+2.6%	11	before history	2.06%
TLPH	Talphera, Inc. Healthcare	Added	5,169,501	+1,815,585	$5,324,586	+111.7%	11	before history	1.99%
AVIR	Atea Pharmaceuticals, Inc. Healthcare	Reduced	1,070,550	-101,305	$4,978,057	−21.0%	2	$4.59	1.86%
MYO	Myomo, Inc. Healthcare	Reduced	3,637,886	-209,386	$3,783,401	+45.5%	11	before history	1.42%
NRXS	Neuraxis, INC Healthcare	Added	508,055	+221,917	$3,713,882	+75.4%	3	$4.91	1.39%
OVID	Ovid Therapeutics Inc. Healthcare	Held	1,107,994	0	$2,980,503	+21.2%	2	$1.79	1.12%
ABVX	Abivax S.A. Healthcare	NEW	20,869	NEW	$2,781,002	NEW	1	$113.18	1.04%
NSPR	InspireMD, Inc. Healthcare	Held	3,905,743	0	$2,734,020	−57.1%	11	before history	1.02%
RGNT	Regentis Biomaterials Ltd. Healthcare	Added	701,685	+450,175	$2,476,948	+222.4%	3	unpriced	0.93%
PYPD	PolyPid Ltd. Healthcare	Reduced	389,455	-208,471	$1,978,431	−24.5%	10	$4.49	0.74%
BFRI	Biofrontera Inc. Healthcare	Added	1,275,609	+111,647	$1,206,726	+28.2%	10	$1.01	0.45%
KURA	Kura Oncology, Inc. Healthcare	Held	100,000	0	$1,097,000	+34.9%	6	$7.79	0.41%
SPRB	Spruce Biosciences, Inc. Healthcare	NEW	20,000	NEW	$1,080,000	NEW	1	$55.91	0.40%
AQST	Aquestive Therapeutics, Inc. Healthcare	Held	250,000	0	$1,040,000	+0.2%	2	$4.06	0.39%
OKUR	OnKure Therapeutics, Inc. Healthcare	Reduced	150,000	-293,763	$684,000	−62.8%	3	$2.99	0.26%
PEPG	PepGen Inc. Healthcare	NEW	350,000	NEW	$630,000	NEW	1	$1.63	0.24%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.